114 related articles for article (PubMed ID: 38598875)
1. Development and validation of a novel nomogram for predicting overall survival patients with neuroblastoma.
Zhao JD; Lu XY; Chen TP; Duan XL; Zuo W; Sai K; Zhu LR; Gao Q
Eur J Surg Oncol; 2024 Jun; 50(6):108321. PubMed ID: 38598875
[TBL] [Abstract][Full Text] [Related]
2. A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
Moreno L; Guo D; Irwin MS; Berthold F; Hogarty M; Kamijo T; Morgenstern D; Pasqualini C; Ash S; Potschger U; Ladenstein R; Valteau-Couanet D; Cohn SL; Pearson ADJ; London WB
Pediatr Blood Cancer; 2021 Mar; 68(3):e28794. PubMed ID: 33205902
[TBL] [Abstract][Full Text] [Related]
3. A novel clinical tool and risk stratification system for predicting the event-free survival of neuroblastoma patients: A TARGET-based study.
Li M; Duan X; Li C; You D; Liu L
Medicine (Baltimore); 2023 Sep; 102(38):e34925. PubMed ID: 37746942
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification.
Feng L; Kan Y; Wang W; Wang C; Zhang H; Xie P; Yang J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16377-16390. PubMed ID: 37702807
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of Novel Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Patients With Soft Tissue Sarcoma.
Tu Q; Hu C; Zhang H; Kong M; Peng C; Song M; Zhao C; Wang Y; Ma X
Technol Cancer Res Treat; 2021; 20():1533033821997828. PubMed ID: 33706618
[TBL] [Abstract][Full Text] [Related]
6. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
[TBL] [Abstract][Full Text] [Related]
7. Prognostic nomogram for predicting 5-year overall survival in Chinese patients with high-grade osteosarcoma.
Yao Z; Tan Z; Yang J; Yang Y; Wang C; Chen J; Zhu Y; Wang T; Han L; Zhu L; Yang Z
Sci Rep; 2021 Sep; 11(1):17728. PubMed ID: 34489489
[TBL] [Abstract][Full Text] [Related]
8. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma.
Sun Q; Chen Y; Jin Q; Yuan X
Eur J Pediatr; 2022 Dec; 181(12):4135-4147. PubMed ID: 36149505
[TBL] [Abstract][Full Text] [Related]
9. Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study based on SEER database.
Ding R; Su Z; Chen M; Chen L
Medicine (Baltimore); 2023 Jul; 102(28):e34313. PubMed ID: 37443499
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors.
Dong S; Liang J; Zhai W; Yu Z
Am J Clin Oncol; 2020 Sep; 43(9):607-614. PubMed ID: 32889829
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
12. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
Dang J; Xu G; Guo G; Zhang H; Shang L
J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals.
Wu R; Li X; Chen Z; Shao Q; Zhang X; Tang W; Hu B
BMC Pediatr; 2023 Aug; 23(1):426. PubMed ID: 37633889
[TBL] [Abstract][Full Text] [Related]
14. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
15. Comparing overall survival between pediatric and adult retinoblastoma with the construction of nomogram for adult retinoblastoma: A SEER population-based analysis.
Yin F; Guo Z; Sun W; Hou C; Wang S; Ji F; Liu Y; Fu S; Liu C; Li R; Wang Y; Sun D
Asian J Surg; 2024 May; 47(5):2178-2187. PubMed ID: 38395709
[TBL] [Abstract][Full Text] [Related]
16. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma.
Yu Y; Wang S; Liu J; Ge J; Guan H
Sci Rep; 2023 Jun; 13(1):10230. PubMed ID: 37353555
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
